Barclays analyst Matt Miksic lowered the firm’s price target on ZimVie to $5 from $9 and keeps an Underweight rating on the shares. The company’s Q4 shortfall and guidance below the Street drove a significant pullback in the stock, the analyst tells investors in a research note.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on ZIMV:
- ZimVie Reports Fourth Quarter and Full Year 2022 Financial Results
- ZimVie announces launch of RealGUIDE CAD, FULL SUITE software modules
- ZimVie Announces Launch of the RealGUIDE™ CAD and FULL SUITE Software Modules
- ZimVie to Report Fourth Quarter and Full Year 2022 Financial Results on March 1, 2023
- ZimVie Announces Over 200,000 Cervical Discs Have Been Replaced with Mobi-C®